Pieris Pharmaceuticals (NASDAQ:PIRS) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Sunday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Price Performance Shares of Pieris Pharmaceuticals stock opened at $0.19 on Friday. Pieris Pharmaceuticals has a twelve month low of $0.14 and a […]
More Stories
Consumer Spending Holds Firm Amid Tariff Pressures, Bank of America Finds
By Tom Ozimek U.S. consumer spending continued to show resilience in March, bolstered by higher-income households and targeted spending ahead...
House Passes Bill to Require Proof of Citizenship to Vote
By Joseph Lord and Jackson Richman The House on April 10 gave the nod to a bill that would enhance...
Six Die After Helicopter Crashes in the Hudson River Near Manhattan
By Jacob Burg A helicopter crashed into the Hudson River just off Manhattan on April 10, killing all six on...
CIBC Private Wealth Group LLC Has $33,000 Stock Position in Fox Co. (NASDAQ:FOXA)
CIBC Private Wealth Group LLC increased its holdings in shares of Fox Co. (NASDAQ:FOXA – Free Report) by 122.3% during...
O Shaughnessy Asset Management LLC Sells 1,036 Shares of Qualys, Inc. (NASDAQ:QLYS)
O Shaughnessy Asset Management LLC reduced its stake in Qualys, Inc. (NASDAQ:QLYS – Free Report) by 21.2% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...